Patents for C07D 209 - Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom (45,780) |
---|
12/24/2013 | DE112012000828T5 Lichtemittierendes Element The light-emitting element |
12/24/2013 | CA2714181C Ampk modulators |
12/19/2013 | WO2013187696A1 Indole based compound having selective inhibiting activity on genome replication of hepatitis c virus, production method for same, and pharmaceutical composition for preventing or treating hepatitis c containing same as active ingredient |
12/19/2013 | WO2013186039A1 Crop enhancement compositions |
12/19/2013 | WO2013150545A3 Process for preparation of benzimidazole derivatives and salts thereof |
12/19/2013 | US20130338374 Gpr 17 agonists and screening assay |
12/19/2013 | US20130338371 Method for producing aromatic compound having ring structure that includes nitrogen atom or oxygen atom |
12/19/2013 | US20130338208 Fulvene and fulvalene analogs and their use in treating cancers |
12/19/2013 | US20130338158 6-substituted indole-3-carboxylic acid amide compounds having sphingosine-1-phosphate (s1p) receptor antagonist biological activity |
12/19/2013 | US20130336919 Compounds and methods for inhibiting phosphate transport |
12/18/2013 | EP2674418A1 Biscarbazole derivative and organic electroluminescent element using same |
12/18/2013 | EP1276721B1 Methylation of indole compounds using dimethyl carbonate |
12/18/2013 | CN103459438A Polymerizable compound, polymerizable composition, polymer, and optically anisotropic body |
12/18/2013 | CN103450883A Organic electronic material |
12/18/2013 | CN103450074A R-L-prolinol chiral organic small molecule compound with cyclopropane structure and synthesis method of R-L-prolinol chiral organic small molecule compound |
12/18/2013 | CN103450073A R-diphenyl prolinol chiral organic small molecule compound with cyclopropane structure and synthesis method of R-diphenyl prolinol chiral organic small molecule compound |
12/18/2013 | CN103450072A Pyrrole derivative of R-proline with cyclopropane structure and preparation method of pyrrole derivative |
12/18/2013 | CN103450071A Asymmetric synthesis method of medical intermediate 2-azabicyclo [3. 1. 0] hexane-2, 3-tert-butyl dicarbonate |
12/18/2013 | CN103450070A Synthesis process of xylylenimine |
12/18/2013 | CN103450069A Preparation method of mitiglinide calcium |
12/18/2013 | CN103450068A Synthetic method of ziprasidone intermediate |
12/18/2013 | CN103450067A Bi[indole-3-yl-acetylamino acid] connected by ethyl, preparation method, antithrombotic function, and applications thereof |
12/18/2013 | CN103450066A Preparation method of Telaprevir intermediate |
12/18/2013 | CN102786463B Method for preparing 5-acetoxyl-3-indole carboxylic acid ethyl ester |
12/18/2013 | CN101595080B Fluoranthene compound, organic electroluminescent device using fluoranthene compound, and organic electroluminescent material-containing solution |
12/17/2013 | US8609873 Process for making and using HOF.RCN |
12/17/2013 | US8609656 Heteroarylphenylurea derivative |
12/17/2013 | CA2774250C C-linked hydroxamic acid derivatives useful as antibacterial agents |
12/17/2013 | CA2536995C Crystalline sulfonamide-containing indole compound and process for preparing the same |
12/12/2013 | WO2013185124A1 Antimicrobial compounds, compositions and methods of use thereof |
12/12/2013 | WO2013183851A1 Novel organic electroluminescent element compound and organic electroluminescent element comprising same |
12/12/2013 | WO2013182046A1 Organic electronic material and organic electroluminescent device |
12/12/2013 | US20130331570 Aryl urea derivatives as n-formyl peptide receptor like-1 (fprl-1) receptor modulators |
12/12/2013 | US20130331568 Acetylene derivatives having mglur 5 antagonistic activity |
12/12/2013 | US20130331419 Mineralocorticoid receptor antagonists |
12/11/2013 | EP2671869A1 Tetrahydroisoquinoline derivative |
12/11/2013 | EP2670734A1 Novel ether linked compounds and improved treatments for cardiac and cardiovascular disease |
12/11/2013 | EP2670733A2 Hdac inhibitors and therapeutic methods using the same |
12/11/2013 | CN103443076A Indol-2-one derivatives disubstituted in the 3-osition, preparation thereof and therapeutic use thereof |
12/11/2013 | CN103436252A Anion fluorescent probe for forming aggregate through anion inducing |
12/11/2013 | CN103435722A Photoinitiators for UV-LED curable compositions and inks |
12/11/2013 | CN103435606A CDK2 and CSK3beta dual inhibitor and application thereof |
12/11/2013 | CN103435553A Piperazine structure-based aryl formamide Raf kinase inhibitor and preparation method as well as application thereof |
12/11/2013 | CN103435537A Electro-polymerizable chemically-modified electrode organic material and application of electrode organic material in ultra-trace TNT (Trinitrotoluene) detection |
12/11/2013 | CN103435536A Pyrrole derivative of S-proline having cyclopropane structure and preparation method of pyrrole derivative |
12/11/2013 | CN103435535A Preparation method of R-proline having cyclopropane structure |
12/11/2013 | CN103435534A Preparation method of S-proline having cyclopropane structure |
12/11/2013 | CN103435533A Chiral organic small molecular compound of S-prolinol having cyclopropane structure and synthetic method of chiral organic small molecular compound |
12/11/2013 | CN103435532A Synthetic method of boceprevir intermediate |
12/11/2013 | CN103435531A Method for preparing feed additive DL-tryptophan |
12/11/2013 | CN103435530A Preparation method of D-tryptophan lower alcohol ester hydrochloride with high optical purity |
12/11/2013 | CN103435529A N-substituted bisindole compound and preparation method thereof |
12/11/2013 | CN103435528A Simple synthesis process of important pharmaceutical chemical intermediate 5-nitroindole |
12/11/2013 | CN103435448A High-stereoselectivity method for reducing alkynylamines |
12/11/2013 | CN102533252B Organic luminescent material and organic electroluminescent device |
12/11/2013 | CN102442965B PAR-1 (protease-activated receptor-1) antagonists for treating thrombotic diseases, as well as preparation and application thereof |
12/11/2013 | CN102432519B Preparation method of 3-(2-aminoethyl)-N-methyl-1H-indole-5-methanesulfonamide |
12/11/2013 | CN102153538B Benzocyclodirivative |
12/11/2013 | CN101516844B 4-heteroaryl-substituted 1-aminocyclohexane-1- and cyclohexene-1-derivatives having effects on the opiod receptor system |
12/10/2013 | US8604219 Method for synthesis of N-alkyl carbazole and derivatives thereof |
12/10/2013 | US8604074 Pro-neurogenic compounds |
12/10/2013 | US8603647 Anthracene derivative, material for light emitting element, light emitting element, light emitting device, and electronic device |
12/10/2013 | CA2810655C Modulators of atp-binding cassette transporters |
12/05/2013 | WO2013180656A1 ICMT Inhibitors |
12/05/2013 | WO2013180478A1 Novel organic electroluminescence compounds and organic electroluminescence device containing the same |
12/05/2013 | WO2013180456A1 Novel organic electroluminescent compounds and organic electroluminescent device comprising the same |
12/05/2013 | WO2013180350A1 Novel low-molecule compound for promoting pluripotent stem cell generation, maintenance, and proliferation, and composition and culturing method containing same |
12/05/2013 | WO2013180241A1 Organic electroluminescence element and material for organic electroluminescence element |
12/05/2013 | WO2013180097A1 Organic electroluminescent element |
12/05/2013 | WO2013179297A1 Process for preparation of (1s, 3s, 5s)-2-[(2s)-2-amino-2-(3-hydroxy-1-adamantyl) acetyl]-2-azabicyclo [3.1.0] hexane-3-carbonitrile |
12/05/2013 | WO2013153479A3 Indole and indazole compounds that activate ampk |
12/05/2013 | US20130324717 Copolymerizable methine and anthraquinone compounds and articles containing them |
12/05/2013 | US20130324540 Use of glutaric acid derivatives or the pharmaceutically acceptable salts thereof as anti-arrhythmic agents |
12/05/2013 | US20130324522 Insect odorant receptor antagonists |
12/04/2013 | EP2669272A1 Indole derivative and pharmacologically acceptable salt of same |
12/04/2013 | EP2669271A1 Indole derivative, and pharmacologically acceptable salt thereof |
12/04/2013 | EP2669270A1 Ring-fused compound |
12/04/2013 | EP2668159A1 4-tolyl-ethynyl-octahydro-indole-1-ester derivatives |
12/04/2013 | CN103430344A Light-emitting element material and light-emitting element |
12/04/2013 | CN103429570A Bis-carbazole derivative and organic electroluminescent element using same |
12/04/2013 | CN103429569A New azaspirodecanone compounds |
12/04/2013 | CN103429567A Process for preparing chiral amino acids |
12/04/2013 | CN103421488A Synthesis and application of fluorescent probe capable of reversibly detecting hypoxic environment |
12/04/2013 | CN103421487A Novel electroluminescent material and application thereof |
12/04/2013 | CN103420917A Benzamide compounds containing fused ring structure and applications thereof as antitumor medicaments |
12/04/2013 | CN103420897A Triptycene derivative and application thereof |
12/04/2013 | CN103420896A Preparation method for 5-benzyl-7(S)-t-butyloxycarborylamino-5-aza-spiro[2,4]heptanes |
12/04/2013 | CN103420895A Preparation method of 4-aminoindole |
12/04/2013 | CN103420894A 2- butane-1,4-diketone compounds, preparation method and applications |
12/04/2013 | CN103420893A Method for preparing silodosin intermediate |
12/04/2013 | CN103420892A Preparation method of 4-fluoroindole |
12/04/2013 | CN102911105B 3-aroyl indole compound synthesis method |
12/04/2013 | CN102718693B Carbazochrome sodium sulfonate compound and composition thereof |
12/04/2013 | CN102643654B Liquid crystal photo-alignment material and application thereof |
12/04/2013 | CN102618610B Preparation method of sericin compound amino acid |
12/04/2013 | CN101663314B Crystalline forms of the mono-sodium salt of d-isoglutamyl-d-tryptophan |
12/04/2013 | CN101553463B New pharmaceutical intermediates in the synthesis of ace- inhibitors and the use thereof |
12/03/2013 | US8598370 Process for producing threo-3-(3,4-dihydroxyphenyl)-L-serine |
12/03/2013 | US8598223 Crystalline forms of 4, 4′-[4-fluoro-7-({4-[4-(3-fluoro-2-methylphenyl) butoxy] phenyl} ethynyl)-2-methyl-1H-indole-1,3-diyl] dibutanoic acid, 4,4′-[2-methyl-7-({4-[4-(pentafluorophenyl) butoxy] phenyl} ethynyl)-1H-indole-1, 3-diyl] dibutanoic acid, and 4,4′-[4-fluoro-2-methyl-7-({4-[4-(2, 3, 4, 6-tetrafluorophenyl) butoxy] phenyl} ethynyl)-1H-indole-1, 3-diyl] dibutanoic acid |
12/03/2013 | US8598180 Tetrahydroindolone derivatives for treatment of neurological conditions |